Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 4 I, 1996, Pages 1092-1098

  Tremblay, Guy M ^b   Sallenave, Jean Michel ^b   Israël Assayag, Evelyne ^b   Cormier, Yvon ^b   Gauldie, Jack ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ELAFIN; ELASTASE INHIBITOR; SERINE PROTEINASE INHIBITOR;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FARMER LUNG; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LUNG ALVEOLITIS; LUNG DISEASE; LUNG FUNCTION TEST; LUNG LAVAGE; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL;

EID: 0029911461     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.4.8887613     Document Type: Article

References (35)

1. Hubbard, R. C., M. L. Brantly, and R. G. Crystal. 1991. Proteases. In R. G. Crystal, J. B. West, P. J. Barnes, N. S. Cherniack, and E. R. Weibel, editors. The Lung: Scientific Foundations. Raven Press, New York. 1763-1773.
2. Hubbard, R. C., and R. G. Crystal. 1991. Antiproteases. In R. G. Crystal, J. B. West, P. J. Barnes, N. S. Cherniack, and E. R. Weibel, editors. The Lung: Scientific Foundations. Raven Press, New York. 1775-1787.
3. Sallenave, J.-M., A. Silva, M. E. Marsden, and A. P. Ryle. 1993. Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines. Am. J. Respir. Cell Mol. Biol. 8:126-133.
4. Rao, N. V., N. G. Wehner, B. C. Marshall, W. R. Gray, B. H. Gray, and J. R. Hoidal. 1991. Characterization of proteinase-3 (PR-3), a neutrophil serine protease. Structural and functional properties. J. Biol. Chem. 266:9540-9548.
5. Abrams, W. R., A. M. Fein, U. Kucich, F. Kueppers, H. Yamada, T. Kuzmowycz, L. Morgan, M. Lippmann, S. K. Goldberg, and G. Weinbaum. 1984. Proteinase inhibitory function in inflammatory lung disease. 1. Acute bacterial pneumonia. Am. Rev. Respir. Dis. 129:735-741.
6. 1-proteinase inhibitor and bronchial inhibitor content of bronchoalveolar lavage fluids from healthy subjects. Biol. Chem. Hoppe Seyler 368:981-990.
7. 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin. Sci. 72:373-381.
8. 2-Proteinase inhibitor and mucus proteinase inhibitor in human lung emphysema. Clin. Invest. 70:269-276.
9. Kawauchi, I., S. Yasuoka, Y. Ueda, and T. Ogura. 1993. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases. Tokushima. J. Exp. Med. 40:95-107.
10. Birrer, P., N. G. McElvaney, A. Rüdeberg, C. Wirz Sommer, S. Liechti-Gallati, R. Kraemer, R. Hubbard, and R. G. Crystal. 1994. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150:207-213.
11. Wiedow, O., J.-M. Schröder, H. Gregory, J. A. Young, and E. Christofers. 1990. Elafin: an elatase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J. Biol. Chem. 265:14791-14795.
12. Sallenave, J.-M., and A. P. Ryle. 1991. Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Biol. Chem. Hoppe Seyler 372:13-21.
13. Sallenave, J.-M., M. D. Marsden, and A. P. Ryle. 1992. Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity. Biol. Chem. Hoppe Seyler 373:27-33.
14. Sallenave, J.-M., and A. Silva. 1993. Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. Am. J. Respir. Cell Mol. Biol. 8:439-445.
15. Wiedow, O., J. Lüdemann, and B. Utecht. 1991. Elafin is a potent inhibitor of proteinase 3. Biochem. Biophys. Res. Commun. 174:6-10.
16. Sibille, Y., J. B. Martinot, P. Staquet, L. Delaunois, B. Chatelain, and D. L. Delacroix. 1988. Antiproteases are increased in bronchoalveolar lavage in interstitial lung disease. Eur. Respir. J. 1:498-504.
17. Cormier, Y., and M. Schuyler. 1992. Hypersensitivity pneumonitis. In R. C. Bone, editor. Textbook of Pulmonary Medicine, Vol. 2, Part M: Interstitial Lung Disease. Mosby Year Book, St. Louis. 1-9.
18. Lalancette, M., G. Carrier, M. Laviolette, S. Ferland, J. Rodrique, R. Bégin, A. Cantin, and Y. Cormier. 1993. Farmer's lung: long-term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factors. Am. Rev. Respir. Dis. 148:216-221.
19. Vogelmeier, C., F. Krombach, S. Münzing, S. König, G. Mazur, T. Beinert, and G. Fruhmann. 1993. Activation of blood neutrophils in acute episodes of farmer's lung. Am. Rev. Respir. Dis. 148:396-400.
20. Walker, C., W. Bauer, R. K. Braun, G. Menz, P. Braun, F. Schwarz, T. T. Hansel, and B. Villiger. 1994. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir. Crit. Care Med. 150: 1038-1048.
21. Sallenave, J. -M., J. Shulmann, J. Crossley, M. Jordana, and J. Gauldie. 1994. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11:733-741.
22. Michalski, J. P., C. C. McCombs, S. Sheth, M. McCarthy, and R. deShazo. 1985. A modified double antibody sandwich enzyme-linked immunosorbent assay for measurement of alpha-1-antitrypsin in biologic fluids. J. Immunol. Methods 83:101-112.
23. Afford, S. C., R. A. Stockley, J. A. Kramps, J. H. Dijkman, and D. Burnett. 1985. Concentration of bronchoalveolar lavage fluid by ultrafiltration: evidence of differential protein loss and functional inactivation of proteinase inhibitors. Anal. Biochem. 151:125-130.
24. Steel, R. G. D., and J. H. Torrie. 1980. Principles and Procedures of Statistics. A Biometrical Approach, 2nd ed. McGraw-Hill Book Co., New York.
25. 1-Antitrypsin: structure, function, physiology. In A. Mackiewicz, I. Kushner, and H. Baumann, editors. Acute Phase Proteins. Molecular Biology, Biochemistry, and Clinical Applications. CRC Press, Boca Raton. 149-167.
26. Mooren, H. W. D., J. A. Kramps, C. Franken, C. J. L. M. Meijer, and J. A. Dijkman. 1983. Localisation of a low-molecular-weight bronchial protease inhibitor in the peripheral human lung. Thorax 38: 180-183.
27. Abbinante-Nissen, J. M., L. G. Simpson, and G. D. Leikauf. 1993. Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 265:L286-L292.
28. Nonomura, K., K. Yamanishi, H. Yasuno, K. Nara, and S. Hirose. 1994. Up-regulation of elafin/SKALP gene expression in psoriatic epidermis. J. Invest. Dermatol. 103:88-91.
29. Vandenplas, O., S. Depelchin, L. Delaunois, J.-P. Delwiche, and Y. Sibille. 1994. Bronchoalveolar lavage immunoglobulin A and G and antiproteases correlate with changes in diffusion indices during the natural course of pulmonary sarcoidosis. Eur. Respir. J. 7:1856-1864.
30. Willems, L. N. A., J. A. Kramps, T. Stijnen, P. J. Sterk, J. J. Weening, and J. H. Dijkman. 1989. Antileukoprotease-containing bronchiolar cells. Relationship with morphologic disease of small airways and parenchyma. Am. Rev. Respir. Dis. 139:1244-1250.
31. Twining, S. S. 1994. Regulation of proteolytic activity in tissues. Crit. Rev. Biochem. Mol. Biol. 29:315-383.
32. Boudier, C., and J. G. Bieth. 1994. Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor. Biochem. J. 303:61-68.
33. Van-Seuningen, I., J.-P. Aubert, and M. Davril. 1992. Interaction between secretory leucocyte proteinase inhibitor and bronchial mucins or glycopeptides. Physiopathological implications for the protection of mucins against proteolysis by human leucocyte elastase. Biochem. J. 281:761-766.
34. Molhuizen, H. O. F., H. A. C. Alkemade, P. L. J. M. Zeeuwen, G. J. de Jongh, B. Wieringa, and J. Schalkwijk. 1993. SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. J. Biol. Chem. 268:12028-12032.
35. Llewellyn-Jones, C. G., D. A. Lomas, and R. A. Stockley. 1994. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation. Thorax 49:567-572.